57 related articles for article (PubMed ID: 2258679)
1. [ACE kininase inhibitor].
Nagano M
Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1320-8. PubMed ID: 2258679
[No Abstract] [Full Text] [Related]
2. Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril.
Asdaq SM; Inamdar MN
Phytomedicine; 2010 Nov; 17(13):1016-26. PubMed ID: 20739164
[TBL] [Abstract][Full Text] [Related]
3. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
4. [Progress in the treatment of myocardial diseases].
Toshima H
Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):363-6. PubMed ID: 1970599
[No Abstract] [Full Text] [Related]
5. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
Takeda A; Takeda N
J Mol Cell Cardiol; 1997 Nov; 29(11):2961-5. PubMed ID: 9405171
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M
Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
de Resende MM; Kriegel AJ; Greene AS
J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
10. [Differential use of vasodilators in various types of cardiac insufficiency].
Moiseev VS; Shatkovskiĭ NP; Cheltsov VV
Klin Med (Mosk); 1993; 71(4):21-5. PubMed ID: 8246409
[TBL] [Abstract][Full Text] [Related]
11. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
12. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitors as initial therapy for hypertension.
Schoenberger JA
Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women.
Fan X; Wang Y; Sun K; Zhang W; Yang X; Wang S; Zhen Y; Wang J; Li W; Han Y; Liu T; Wang X; Chen J; Wu H; Hui R;
Clin Pharmacol Ther; 2007 Aug; 82(2):187-96. PubMed ID: 17473847
[TBL] [Abstract][Full Text] [Related]
15. Effect of tensiomin in ischaemic dilatative cardiomyopathy.
Buzási G; Endresz F; Karády S; Böszörményi E
Ther Hung; 1993; 41(2):55-9. PubMed ID: 8278939
[TBL] [Abstract][Full Text] [Related]
16. [Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor].
Baumgart P; Tenschert W; Vetter H
Schweiz Med Wochenschr; 1985 Dec; 115(50):1832-4. PubMed ID: 3003892
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
[No Abstract] [Full Text] [Related]
19. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
